Q2 2017 13F Holders as of 6/30/2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
49.8M
-
Number of holders
-
90
-
Total 13F shares, excl. options
-
46.2M
-
Shares change
-
+609K
-
Total reported value, excl. options
-
$1.84B
-
Value change
-
+$26.5M
-
Number of buys
-
47
-
Number of sells
-
-33
-
Price
-
$39.84
Significant Holders of Theravance Biopharma, Inc. - Common Stock (TBPH) as of Q2 2017
102 filings reported holding TBPH - Theravance Biopharma, Inc. - Common Stock as of Q2 2017.
Theravance Biopharma, Inc. - Common Stock (TBPH) has 90 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 46.2M shares
of 49.8M outstanding shares and own 92.84% of the company stock.
Largest 10 shareholders include Woodford Investment Management Ltd (10.7M shares), BAUPOST GROUP LLC/MA (9.27M shares), FMR LLC (7.85M shares), BlackRock Inc. (3.64M shares), VANGUARD GROUP INC (3.2M shares), FIRST MANHATTAN CO (1.75M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.32M shares), Cormorant Asset Management, LLC (950K shares), STATE STREET CORP (890K shares), and NORGES BANK (803K shares).
This table shows the top 90 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.